Inventor · disambiguated record
Kazutaka Shimbo
Also filed as: SHIMBO KAZUTAKA
12 granted patents·17 pending applications·75 citations·filing 2004–2025
87Inventor score
Top patents by PatentIndex Score
29 records- 0191US9658234B2Method for analysis of compounds with amino group and analytical reagent thereforAJINOMOTO KK·Filed 2016·Granted May 23, 2017·12 cites·15 claims
- 0288US7494815B2Method and apparatus for analyzing compounds with amino groupAJINOMOTO KK·Filed 2006·Granted Feb 24, 2009·25 cites·14 claims
- 0387US7148069B2Method for analysis of compounds with amino group and analytical reagent thereforAJINOMOTO KK·Filed 2004·Granted Dec 12, 2006·32 cites·35 claims
- 0486US12024549B2Compound having affinity substance to soluble protein, cleavable portion and reactive group, or salt thereofAJINOMOTO KK·Filed 2019·Granted Jul 2, 2024·3 cites·14 claims
- 0576US2025020656A1Evaluating method, evaluating apparatus, evaluating program product, evaluating system, and terminal apparatusAJINOMOTO KK·Filed 2024·Application pending·0 cites
- 0675US2025302985A1Compound having affinity substance to antibody and bioorthogonal functional group, or salt thereofAJINOMOTO KK·Filed 2025·Application pending·0 cites
- 0775US2025367317A1Compound having affinity substance to antibody and bioorthogonal functional group, or salt thereofAJINOMOTO KK·Filed 2025·Application pending·0 cites
- 0872US2024366783A1Compound having affinity substance to soluble protein, cleavable portion and reactive group, or salt thereofAJINOMOTO KK·Filed 2024·Application pending·0 cites
- 0963US9274123B2Method for analysis of compounds with amino group and analytical reagent thereforMIYANO HIROSHI·Filed 2006·Granted Mar 1, 2016·2 cites·20 claims
- 1062US2024058473A1Complex or salt thereof, and method for producing the sameAJINOMOTO KK·Filed 2023·Application pending·0 cites
- 1162US2021139541A1Compound having affinity substance to antibody and bioorthogonal functional group, or salt thereofAJINOMOTO KK·Filed 2020·Application pending·0 cites
- 1261US12492370B2Method for producing protein using a Talaromyces cellulolyticus strain having reduced activity of PEP4AJINOMOTO KK·Filed 2022·Granted Dec 9, 2025·0 cites·19 claims
- 1358US10717971B2Protein deamidaseAJINOMOTO KK·Filed 2016·Granted Jul 21, 2020·0 cites·12 claims
- 1458US9952235B2Standard solution for use in analysis of amino acids in plasmaWAKO PURE CHEM IND LTD·Filed 2017·Granted Apr 24, 2018·0 cites·15 claims
- 1558US9638706B2Standard solution for use in analysis of amino acid in plasmaHAYAKAWA MASAKO·Filed 2012·Granted May 2, 2017·1 cites·12 claims
- 1658US2022088111A1Peptide and use thereofAJINOMOTO KK·Filed 2021·Application pending·0 cites
- 1758US2025312407A1Peptide and use thereofAJINOMOTO KK·Filed 2025·Application pending·0 cites
- 1858US2023279063A1Modified ferritin and method for producing the sameAJINOMOTO KK·Filed 2022·Application pending·0 cites
- 1956US10941390B2Protein deamidaseAJINOMOTO KK·Filed 2020·Granted Mar 9, 2021·0 cites·4 claims
- 2056US2025352448A1Composition for improving skin conditionsAJINOMOTO KK·Filed 2025·Application pending·0 cites
- 2153US2018017570A1Evaluating method, evaluating apparatus, evaluating program product, evaluating system, and terminal apparatusAJINOMOTO KK·Filed 2017·Application pending·0 cites
- 2251US2021239714A1Test method for olfactory mucosa or olfactory mucus in mammalsAJINOMOTO KK·Filed 2021·Application pending·0 cites
- 2350US12428450B2Compound having affinity substance to antibody, cleavable portion, and reactive group, or salt thereofAJINOMOTO KK·Filed 2021·Granted Sep 30, 2025·0 cites·6 claims
- 2450US2021139549A1Compound having affinity substance to antibody, cleavable portion, and reactive group, or salt thereofAJINOMOTO KK·Filed 2020·Application pending·0 cites
- 2543US2019228844A1Evaluating method, evaluating apparatus, evaluating program product, evaluating system, and terminal apparatus for colorectal cancerAJINOMOTO KK·Filed 2019·Application pending·0 cites
- 2643US2019227071A1Evaluating method, evaluating apparatus, evaluating program product, evaluating system, and terminal apparatus for pancreatic cancerAJINOMOTO KK·Filed 2019·Application pending·0 cites
- 2741US2019137516A1Evaluating method for future risk of developing alzheimer's diseaseAJINOMOTO KK·Filed 2019·Application pending·0 cites
- 2841US2019277862A1Evaluating method for mild cognitive impairment or alzheimer's diseaseAJINOMOTO KK·Filed 2019·Application pending·0 cites
- 2940US11327060B2Method for analyzing enantiomerAJINOMOTO KK·Filed 2018·Granted May 10, 2022·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →